Standard
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery. / Urbanska, Edyta Maria; Santoni-Rugiu, Eric; Melchior, Linea Cecilie; Carlsen, Jonathan Frederik; Sørensen, Jens Benn.
I:
Clinical Lung Cancer, Bind 22, Nr. 4, 2021, s. e528-e532.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Urbanska, EM
, Santoni-Rugiu, E, Melchior, LC
, Carlsen, JF & Sørensen, JB 2021, '
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery',
Clinical Lung Cancer, bind 22, nr. 4, s. e528-e532.
https://doi.org/10.1016/j.cllc.2020.04.012APA
Urbanska, E. M.
, Santoni-Rugiu, E., Melchior, L. C.
, Carlsen, J. F., & Sørensen, J. B. (2021).
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
Clinical Lung Cancer,
22(4), e528-e532.
https://doi.org/10.1016/j.cllc.2020.04.012Vancouver
Urbanska EM
, Santoni-Rugiu E, Melchior LC
, Carlsen JF, Sørensen JB.
Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery.
Clinical Lung Cancer. 2021;22(4):e528-e532.
https://doi.org/10.1016/j.cllc.2020.04.012Author
Urbanska, Edyta Maria ; Santoni-Rugiu, Eric ; Melchior, Linea Cecilie ; Carlsen, Jonathan Frederik ; Sørensen, Jens Benn. / Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery. I: Clinical Lung Cancer. 2021 ; Bind 22, Nr. 4. s. e528-e532.
Bibtex
@article{d625fa62f8b14335a29bede6d046b5db,
title = "Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery",
author = "Urbanska, {Edyta Maria} and Eric Santoni-Rugiu and Melchior, {Linea Cecilie} and Carlsen, {Jonathan Frederik} and S{\o}rensen, {Jens Benn}",
year = "2021",
doi = "10.1016/j.cllc.2020.04.012",
language = "English",
volume = "22",
pages = "e528--e532",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "4",
}
RIS
TY - JOUR
T1 - Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery
AU - Urbanska, Edyta Maria
AU - Santoni-Rugiu, Eric
AU - Melchior, Linea Cecilie
AU - Carlsen, Jonathan Frederik
AU - Sørensen, Jens Benn
PY - 2021
Y1 - 2021
U2 - 10.1016/j.cllc.2020.04.012
DO - 10.1016/j.cllc.2020.04.012
M3 - Journal article
C2 - 32651064
VL - 22
SP - e528-e532
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
SN - 1525-7304
IS - 4
ER -
